Less Frequent Dosing With MS Drug Safe With No Loss of Efficacy Less Frequent Dosing With MS Drug Safe With No Loss of Efficacy

Patients with MS stable on natalizumab administered every 4 weeks may be able to safely switch to every-6-weeks dosing with no clinically meaningful loss of efficacy.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news